Microchip issued a press release indicating its December quarter would come in at the high end of guidance. The company has experienced a massive hangover following the pandemic-era industrial chip ...

Shares of Microchip Technology (MCHP) rose about 7% on Wednesday after the company's revised revenue and EPS outlook for the third quarter of fiscal 2026, ending Dec. 31, came above estimates. While ...

Dec 2 (Reuters) - Chipmaker Microchip Technology (MCHP.O), opens new tab on Tuesday raised its expectations for third-quarter net sales and earnings per share, driven by strong bookings, sending its ...

Machines like cyclotrons and synchrotrons help scientists recreate the conditions of the Big Bang and probe the very edges of particle physics. They also tend to be very big. Now, a new study details ...

While companies like Elon Musk’s Neuralink are hard at work on brain-computer interfaces that require surgery to cut open the skull and insert a complex array of wires into a person’s head, a team of ...

Microchip Technology and Qualcomm have both expanded their presence in Bengaluru, reinforcing the city's position as India's top semiconductor and technology hub and adding momentum to a wave of ...

Sur said Microchip delivered a solid September quarter, with improving fundamentals and stronger-than-expected revenue and margins, even as customers delayed restocking due to macroeconomic and trade ...

Microchip Technology Inc. (NASDAQ:MCHP) shares declined 3.12% in after-hours trading to $57.50 on Thursday. Check out the current price of MCHP stock here. For the second quarter, which ended on ...

Nov 6 (Reuters) - Microchip Technology (MCHP.O), opens new tab forecast third-quarter net sales below Wall Street estimates on Thursday, indicating tepid demand for its chips as customers in the ...

Journal Editorial Report: The week's best and worst from Kim Strassel, Kyle Peterson, Allysa Finley and Dan Henninger. We are in the microchip era, which promises an industrial revolution that will ...

A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...